美国 · SEC FORM 4
SUPERNUS PHARMACEUTICALS, INC.
SUPN · Nasdaq · CIK 0001356576 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
10 同一窗口内观察到的 Form 4 交易行
0 sales · 10 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 4,985,929
- 上期报告
- 4,989,421
- 日均成交量
- 675,999
- 回补天数
- 7.4
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
本地 Form 4 历史中没有合资格的代码 P 股票买入。
Form 4 申报证据
96 transaction lines in the latest 365-day window; 434 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | Rubin Jonathan | 期权行权／转换 (M) | Common Stock | 750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-12 | Rubin Jonathan | 代扣税 (F) | Common Stock | 363 | USD 46.57 | USD 16,905 | SEC 申报 ↗ |
| 2026-08-12 | Mottola Frank | 期权行权／转换 (M) | Common Stock | 1,650 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | Rubin Jonathan | 期权行权／转换 (M) | Common Stock | 750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-12 | Rubin Jonathan | 代扣税 (F) | Common Stock | 363 | USD 46.57 | USD 16,905 | SEC 申报 ↗ |
| 2026-08-12 | Mottola Frank | 期权行权／转换 (M) | Common Stock | 1,650 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-12 | Mottola Frank | 代扣税 (F) | Common Stock | 797 | USD 46.57 | USD 37,116 | SEC 申报 ↗ |
| 2026-08-12 | Khattar Jack A. | 期权行权／转换 (M) | Common Stock | 29,849 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-12 | Khattar Jack A. | 代扣税 (F) | Common Stock | 12,642 | USD 46.57 | USD 588,738 | SEC 申报 ↗ |
| 2026-08-12 | DEC TIMOTHY C | 期权行权／转换 (M) | Common Stock | 1,250 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-12 | DEC TIMOTHY C | 代扣税 (F) | Common Stock | 604 | USD 46.57 | USD 28,128 | SEC 申报 ↗ |
| 2026-08-12 | Bhatt Padmanabh P. | 期权行权／转换 (M) | Common Stock | 2,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-08-12 | Bhatt Padmanabh P. | 代扣税 (F) | Common Stock | 1,158 | USD 46.57 | USD 53,928 | SEC 申报 ↗ |
| 2026-03-18 | Bhatt Padmanabh P. | 卖出 (S) | Common Stock | 7,250 | USD 49.60 | USD 359,621 | SEC 申报 ↗ |
| 2026-03-18 | Bhatt Padmanabh P. | 期权行权／转换 (M) | Common Stock | 7,250 | USD 39.40 | USD 285,650 | SEC 申报 ↗ |
| 2026-03-17 | Bhatt Padmanabh P. | 卖出 (S) | Common Stock | 50,000 | USD 50.30 | USD 2,514,886 | SEC 申报 ↗ |
| 2026-03-17 | Bhatt Padmanabh P. | 期权行权／转换 (M) | Common Stock | 50,000 | USD 38.51 | USD 1,925,538 | SEC 申报 ↗ |
| 2026-03-16 | Bhatt Padmanabh P. | 卖出 (S) | Common Stock | 50,000 | USD 50.28 | USD 2,513,925 | SEC 申报 ↗ |
| 2026-03-16 | Bhatt Padmanabh P. | 期权行权／转换 (M) | Common Stock | 50,000 | USD 33.62 | USD 1,681,205 | SEC 申报 ↗ |
| 2026-03-13 | Khattar Jack A. | 卖出 (S) | Common Stock | 35,000 | USD 50.37 | USD 1,763,124 | SEC 申报 ↗ |
| 2026-03-13 | Khattar Jack A. | J (J) | Common Stock | 12,500 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-12 | Hudson Frederick M. | 卖出 (S) | Common Stock | 5,369 | USD 50.61 | USD 271,725 | SEC 申报 ↗ |
| 2026-03-10 | Horich William Todd | 卖出 (S) | Common Stock | 4,439 | USD 55.00 | USD 244,145 | SEC 申报 ↗ |
| 2026-03-09 | Mottola Frank | 卖出 (S) | Common Stock | 1,623 | USD 53.65 | USD 87,074 | SEC 申报 ↗ |
| 2026-03-09 | Horich William Todd | 卖出 (S) | Common Stock | 4,438 | USD 54.00 | USD 239,652 | SEC 申报 ↗ |
| 2026-03-06 | Mottola Frank | 期权行权／转换 (M) | Common Stock | 3,750 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-06 | Mottola Frank | 代扣税 (F) | Common Stock | 1,793 | USD 54.73 | USD 98,131 | SEC 申报 ↗ |
| 2026-03-06 | Khattar Jack A. | 期权行权／转换 (M) | Common Stock | 38,640 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-06 | Khattar Jack A. | 代扣税 (F) | Common Stock | 16,574 | USD 54.73 | USD 907,095 | SEC 申报 ↗ |
| 2026-03-06 | Horich William Todd | 期权行权／转换 (M) | Common Stock | 7,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-06 | Horich William Todd | 代扣税 (F) | Common Stock | 3,455 | USD 54.73 | USD 189,092 | SEC 申报 ↗ |
| 2026-03-06 | DEC TIMOTHY C | 期权行权／转换 (M) | Common Stock | 3,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-06 | DEC TIMOTHY C | 代扣税 (F) | Common Stock | 2,883 | USD 54.73 | USD 157,787 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | SUPN |
| CIK | 0001356576 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 434 transaction lines from 2020-02-21 to 2026-08-12 0 P purchase lines · 114 S sale lines · 320 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.